Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta
| Autor: | Little, David G., Peacock, Lauren, Mikulec, Kathy, Kneissel, Michaela, Kramer, Ina, Cheng, Tegan L., Schindeler, Aaron, Munns, Craig |
|---|---|
| Zdroj: | In Bone August 2017 101:96-103 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect